These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 21388298)

  • 21. Emergence of imipenem resistance in clinical Escherichia coli during therapy.
    Oteo J; Delgado-Iribarren A; Vega D; Bautista V; Rodríguez MC; Velasco M; Saavedra JM; Pérez-Vázquez M; García-Cobos S; Martínez-Martínez L; Campos J
    Int J Antimicrob Agents; 2008 Dec; 32(6):534-7. PubMed ID: 18775649
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence of plasmid-mediated AmpC beta-lactamases in Escherichia coli and Klebsiella pneumoniae in Korea.
    Lee K; Lee M; Shin JH; Lee MH; Kang SH; Park AJ; Yong D; Chong Y
    Microb Drug Resist; 2006; 12(1):44-9. PubMed ID: 16584308
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of a novel plasmid-mediated cephalosporinase (CMY-9) and its genetic environment in an Escherichia coli clinical isolate.
    Doi Y; Shibata N; Shibayama K; Kamachi K; Kurokawa H; Yokoyama K; Yagi T; Arakawa Y
    Antimicrob Agents Chemother; 2002 Aug; 46(8):2427-34. PubMed ID: 12121914
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increased Antimicrobial Resistance in a Novel CMY-54 AmpC-Type Enzyme with a GluLeu
    Pérez-Llarena FJ; Vázquez-Ucha JC; Kerff F; Zamorano L; Miró E; Cabral MP; Fleites A; Lantero M; Martínez-Martínez L; Oliver A; Galleni M; Navarro F; Beceiro A; Bou G
    Microb Drug Resist; 2018 Jun; 24(5):527-533. PubMed ID: 28665771
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acquisition of Carbapenem Resistance by Plasmid-Encoded-AmpC-Expressing Escherichia coli.
    van Boxtel R; Wattel AA; Arenas J; Goessens WH; Tommassen J
    Antimicrob Agents Chemother; 2017 Jan; 61(1):. PubMed ID: 27799202
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The AmpC phenotype in Norwegian clinical isolates of Escherichia coli is associated with an acquired ISEcp1-like ampC element or hyperproduction of the endogenous AmpC.
    Haldorsen B; Aasnaes B; Dahl KH; Hanssen AM; Simonsen GS; Walsh TR; Sundsfjord A; Lundblad EW
    J Antimicrob Chemother; 2008 Oct; 62(4):694-702. PubMed ID: 18583329
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Detection of NDM-19, a novel variant of the New Delhi metallo-β-lactamase with increased carbapenemase activity under zinc-limited conditions, in Switzerland.
    Mancini S; Keller PM; Greiner M; Bruderer V; Imkamp F
    Diagn Microbiol Infect Dis; 2019 Nov; 95(3):114851. PubMed ID: 31285120
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Circulating of CMY-2 β-lactamase gene in weaned pigs and their environment in a commercial farm and the effect of feed supplementation with a clay mineral.
    Jahanbakhsh S; Letellier A; Fairbrother JM
    J Appl Microbiol; 2016 Jul; 121(1):136-48. PubMed ID: 27138244
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mechanisms of resistance to cephalosporin and emergence of O25b-ST131 clone harboring CTX-M-27 β-lactamase in extraintestinal pathogenic Escherichia coli from dogs and cats in Japan.
    Harada K; Nakai Y; Kataoka Y
    Microbiol Immunol; 2012 Jul; 56(7):480-5. PubMed ID: 22486529
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Point mutations in the inc antisense RNA gene are associated with increased plasmid copy number, expression of blaCMY-2 and resistance to piperacillin/tazobactam in Escherichia coli.
    Kurpiel PM; Hanson ND
    J Antimicrob Chemother; 2012 Feb; 67(2):339-45. PubMed ID: 22117029
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Contribution of asparagine 346 residue to the carbapenemase activity of CMY-2 β-lactamase.
    Dahyot S; Broutin I; de Champs C; Guillon H; Mammeri H
    FEMS Microbiol Lett; 2013 Aug; 345(2):147-53. PubMed ID: 23763375
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Survival in the environment is a possible key factor for the expansion of Escherichia coli strains producing extended-spectrum β-lactamases.
    Starlander G; Yin H; Edquist P; Melhus Å
    APMIS; 2014 Jan; 122(1):59-67. PubMed ID: 23755901
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetic, Biochemical, and Structural Characterization of CMY-136 β-Lactamase, a Peculiar CMY-2 Variant.
    Zavala A; Retailleau P; Elisée E; Iorga BI; Naas T
    ACS Infect Dis; 2019 Apr; 5(4):528-538. PubMed ID: 30788955
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Full-Length Nucleotide Sequences of mcr-1-Harboring Plasmids Isolated from Extended-Spectrum-β-Lactamase-Producing Escherichia coli Isolates of Different Origins.
    Zurfluh K; Klumpp J; Nüesch-Inderbinen M; Stephan R
    Antimicrob Agents Chemother; 2016 Sep; 60(9):5589-91. PubMed ID: 27324774
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Plasmid-Encoded AmpC (pAmpC) in Enterobacteriaceae: epidemiology of microorganisms and resistance markers.
    Cejas D; Fernández Canigia L; Quinteros M; Giovanakis M; Vay C; Lascialandare S; Mutti D; Pagniez G; Almuzara M; Gutkind G; Radice M
    Rev Argent Microbiol; 2012; 44(3):182-6. PubMed ID: 23102467
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterisation of CTX-M and AmpC genes in human isolates of Escherichia coli identified between 1995 and 2003 in England and Wales.
    Hopkins KL; Batchelor MJ; Liebana E; Deheer-Graham AP; Threlfall EJ
    Int J Antimicrob Agents; 2006 Sep; 28(3):180-92. PubMed ID: 16879949
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterisation of plasmids encoding extended-spectrum beta-lactamase and CMY-2 in Escherichia coli isolated from animal farms.
    Blanc V; Cortés P; Mesa RJ; Miró E; Navarro F; Llagostera M
    Int J Antimicrob Agents; 2008 Jan; 31(1):76-8. PubMed ID: 17913469
    [No Abstract]   [Full Text] [Related]  

  • 38. Prevalence of β-lactamase and 16S rRNA methylase genes among clinical Escherichia coli isolates carrying plasmid-mediated quinolone resistance genes from animals.
    Liu BT; Liao XP; Yue L; Chen XY; Li L; Yang SS; Sun J; Zhang S; Liao SD; Liu YH
    Microb Drug Resist; 2013 Jun; 19(3):237-45. PubMed ID: 23289437
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Investigation of plasmid-mediated AmpC beta-lactamase types in Klebsiella spp. and Escherichia coli isolates resistant or intermediate to cefoxitin].
    Demirbakan H; Midilli K; Oğünç D; Ozen N; Ongüt G; Dağlar D; Mutlu D; Ozhak B; Colak D
    Mikrobiyol Bul; 2008 Oct; 42(4):545-51. PubMed ID: 19149075
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibitor-sensitive AmpC beta-lactamase variant produced by an Escherichia coli clinical isolate resistant to oxyiminocephalosporins and cephamycins.
    Doi Y; Wachino J; Ishiguro M; Kurokawa H; Yamane K; Shibata N; Shibayama K; Yokoyama K; Kato H; Yagi T; Arakawa Y
    Antimicrob Agents Chemother; 2004 Jul; 48(7):2652-8. PubMed ID: 15215122
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.